Investors
On December 12, 2024 Double Point Ventures (DPV), a private company, fully acquired Lumos Pharma as a wholly owned subsidiary. Lumos Pharma Inc., under the NASDAQ symbol $LUMO ceased trading on December 12, 2024. Information shown on our website in the section " Media" is provided for historical purposes.
Key Points of Contact
Investor Relations
Lumos Pharma Investor Relations
ir@lumos-pharma.com
512-648-3757
Transfer agents
Computershare Shareowner Services, LLC
PO Box 30170
College Station, TX 77842
Toll-free: 1-888-213-0965
Toll: 201-680-6578